​

Funding Round

Series C - ORIC Pharmaceuticals

Series C - ORIC Pharmaceuticals

Investment Firm

Overview

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Announced Date

Feb 21, 2018

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Fidelity

Fidelity

Fidelity is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed firm.

Participant Investors

9

Investor Name
Participant InvestorMemorial Sloan - Kettering Cancer Center
Participant InvestorForesite Capital
Participant InvestorTaiho Ventures
Participant InvestorThe Column Group
Participant InvestorFidelity

Round Details and Background

ORIC Pharmaceuticals raised $50000000 on 2018-02-21 in Series C

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 26, 2023
Post-IPO Equity - ORIC Pharmaceuticals
6-85.0M
Jan 30, 2024
Post-IPO Equity - ORIC Pharmaceuticals
-125.0M
Nov 01, 2014
Series A - ORIC Pharmaceuticals
1-15.0M
Dec 02, 2015
Series B - ORIC Pharmaceuticals
6-53.0M

Recent Activity

There is no recent news or activity for this profile.